Massachusetts Financial Services Co. MA Increases Position in Procter & Gamble Co (NYSE:PG)

Share on StockTwits

Massachusetts Financial Services Co. MA raised its position in Procter & Gamble Co (NYSE:PG) by 1.3% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,905,308 shares of the company’s stock after purchasing an additional 23,977 shares during the period. Massachusetts Financial Services Co. MA owned 0.08% of Procter & Gamble worth $236,981,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in PG. Krane Funds Advisors LLC acquired a new stake in shares of Procter & Gamble in the 2nd quarter worth $25,000. Camarda Financial Advisors LLC lifted its stake in shares of Procter & Gamble by 59.2% in the second quarter. Camarda Financial Advisors LLC now owns 269 shares of the company’s stock valued at $29,000 after purchasing an additional 100 shares during the period. Lucia Wealth Services LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at about $29,000. Selective Wealth Management Inc. acquired a new stake in shares of Procter & Gamble in the third quarter valued at about $35,000. Finally, Dougherty Wealth Advisers LLC lifted its stake in shares of Procter & Gamble by 250.0% in the second quarter. Dougherty Wealth Advisers LLC now owns 350 shares of the company’s stock valued at $38,000 after purchasing an additional 250 shares during the period. 65.45% of the stock is currently owned by institutional investors.

Several analysts recently commented on the stock. ValuEngine cut shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Goldman Sachs Group reiterated a “buy” rating and issued a $136.00 price objective on shares of Procter & Gamble in a research note on Wednesday, October 23rd. Royal Bank of Canada reiterated a “neutral” rating and issued a $89.00 price objective on shares of Procter & Gamble in a research note on Tuesday, July 30th. Morgan Stanley raised their target price on shares of Procter & Gamble from $130.00 to $134.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. raised their target price on shares of Procter & Gamble from $136.00 to $139.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and ten have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $116.71.

Shares of NYSE PG traded up $1.54 during midday trading on Wednesday, reaching $120.81. 297,920 shares of the stock were exchanged, compared to its average volume of 7,767,040. The company has a market capitalization of $298.51 billion, a P/E ratio of 26.74, a P/E/G ratio of 3.25 and a beta of 0.42. Procter & Gamble Co has a 52-week low of $86.74 and a 52-week high of $125.77. The company has a current ratio of 0.72, a quick ratio of 0.54 and a debt-to-equity ratio of 0.44. The stock has a 50 day moving average price of $121.79 and a 200-day moving average price of $115.23.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $1.37 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.13. The business had revenue of $17.80 billion during the quarter, compared to the consensus estimate of $17.43 billion. Procter & Gamble had a net margin of 6.24% and a return on equity of 25.07%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.12 earnings per share. On average, analysts forecast that Procter & Gamble Co will post 4.93 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.7459 dividend. The ex-dividend date is Thursday, October 17th. This represents a $2.98 dividend on an annualized basis and a yield of 2.47%. Procter & Gamble’s payout ratio is 65.93%.

In other Procter & Gamble news, Director Nelson Peltz sold 206,967 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $124.40, for a total transaction of $25,746,694.80. Following the transaction, the director now directly owns 3,844 shares of the company’s stock, valued at $478,193.60. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Marc S. Pritchard sold 26,075 shares of Procter & Gamble stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $124.96, for a total transaction of $3,258,332.00. Following the transaction, the insider now directly owns 139,066 shares in the company, valued at $17,377,687.36. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,645,966 shares of company stock valued at $202,229,770. 1.75% of the stock is owned by insiders.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Recommended Story: Bollinger Bands

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.